Published in

Karger Publishers, Medical Principles and Practice, 2(14), p. 67-72, 2005

DOI: 10.1159/000083913

Links

Tools

Export citation

Search in Google Scholar

BRCA1 Gene Expression in Breast Cancer in Kuwait: Correlation with Prognostic Parameters

Journal article published in 2005 by M. Amirrad, F. Al-Mulla ORCID, G. Varadharaj, B. John, T. Saji, J. T. Anim
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

<i>Objectives:</i> This study assessed the <i>BRCA1</i> gene expression in breast cancer in Kuwait, and compared it with other known prognostic factors for the disease. <i>Materials and Methods:</i> Forty-eight random samples of archival paraffin-embedded breast cancer tissues were studied for <i>BRCA1</i> gene expression. Immunohistochemical method utilizing antibodies against different epitopes on the BRCA1 protein was used to study BRCA1 protein expression. In addition, for 29 patients, reverse transcription-polymerase chain reaction was used to detect <i>BRCA1</i> mRNA expression. <i>BRCA1</i> expression was correlated with age, histological type and grade of breast cancer, estrogen and progesterone receptor status, and C-erbB-2 expression. <i>Results:</i> No demonstrable <i>BRCA1</i> mRNA and protein expression was found in 79 and 83% of the breast cancer tissues, respectively. A positive relationship was demonstrated between lack of <i>BRCA1</i> (mRNA and protein) expression and high histological grade, negative estrogen and progesterone receptor status, and overexpression of C-erbB-2 in the breast cancer tissues. <i>Conclusions:</i> The study demonstrated lack of <i>BRCA1</i> gene expression (mRNA and protein) in the majority of breast cancers in Kuwait and confirmed the inverse relationship between <i>BRCA1</i> expression and parameters that determine poor prognosis in breast cancer.